Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rejuvenating Face Serum receives Bronze Award

30 Nov 2023 16:05

RNS Number : 2750V
Cellular Goods PLC
30 November 2023
 

30 November 2023

 

Cellular Goods plc

 

("Cellular Goods" or "The Company")

 

Cellular Goods' Rejuvenating Face Serum received the Bronze Award in the esteemed 'Best Product for Ageing Well' category in the 2023 Get The Gloss Beauty Awards

 

Cellular Goods (LSE: CBX), a UK based company pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions, has received the Bronze Award in the 'Best Product for Ageing Well' category at the 2023 Get The Gloss Beauty Awards.

 

The Get The Gloss Beauty Awards are known for their rigorous and transparent nomination process. Industry experts, beauty editors, and influencers come together to evaluate and nominate products that stand out for their innovation, effectiveness, and overall contribution to the beauty landscape. Products are scrutinised based on various criteria, including ingredients, performance, sustainability, and customer reviews.

 

In the realm of skincare innovation, judges for the Get The Gloss Beauty Awards recognised Cellular Goods as a frontrunner, pushing the boundaries of what's possible in the pursuit of ageing well. Cellular Goods' Rejuvenating Face Serum, an innovative serum formulated with the Company's breakthrough anti-inflammatory CBG, to visibly reverse signs of skin ageing as effectively as retinol and vitamin C without the associated dryness or irritation, received a Bronze Award in the 2023 Get the Gloss Beauty Awards for the 'Best Product for Ageing Well' category.

 

In our ever-evolving world of beauty and wellness, recognition for outstanding products and innovation plays a pivotal role in guiding consumers toward the best choices. Get The Gloss is at the forefront of acknowledging excellence in the beauty industry with their annual Beauty Awards. These awards are a testament to the platform's commitment to helping consumers navigate the vast array of beauty products available in the market.

 

Darcy Taylor, Interim CEO at Cellular Goods, commented: "Cellular Goods is elated to have been recognised as a frontrunner in the 2023 Get The Gloss Beauty Awards with our Rejuvenating Face Serum receiving a Bronze Award in the 'Best Product for Ageing Well' category. Get The Gloss provides a valuable platform for Cellular Goods to increase brand awareness and gain traction with new customers as we continue our mission of developing next-generation skincare and wellness products to help people look, feel and function better."

 

For further information please contact:

 

Cellular Goods

Darcy Taylor

Chairman and Interim CEO

via FSCF +44 7572 873 300

First Sentinel Corporate Finance (FSCF)

Investor Relations

Rebecca Noonan

IR@cellular-goods.com

Media Relations

Rebecca Noonan

Media@cellular-goods.com

Corporate Broker & Advisor

Brian Stockbridge

 

+44 7572 873 300

 

 

+44 7572 873 300

 

 

+44 7876 888 011

Novum Securities

 

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427 

 

About Cellular Goods PLC:

Cellular Goods is pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions. The Company launched with a focus on efficacy led and science-backed products utilising biosynthetics, and now employs its expertise across two verticals: premium next-generation cannabinoid skincare products, and carbon sequestration-as-a-service through its wholly owned business division, King Tide Carbon, which utilises biosynthetic algae and seaweed to provide scalable carbon removal.

 

The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com.

 

About Get The Gloss:

Get The Gloss launched in 2012 with the mission to root out the best in health, beauty and wellness. The online destination for expert health and beauty is powered by an in-house team of editors and directory of experts, with over 800,000 views online, 400,000 monthly website users and unrivalled standing within the industry. Working with leading makeup artists, hair stylists, nutritionists, personal trainers, trichologists and wellness practitioners, Get The Gloss brings its readers the expert view on news and trends in beauty and wellness, and creates specialist guides to help its readers be their happiest, healthiest self. Get The Gloss delivers fresh, daily expert-led content to a highly engaged and ever-growing audience across the UK and beyond.

 

For more information, visit: https://www.getthegloss.com/

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFIRLLLIVIV
Date   Source Headline
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSDirectorate change
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20222:05 pmRNSSecond Price Monitoring Extn
14th Mar 20222:00 pmRNSPrice Monitoring Extension
14th Mar 20227:00 amRNSLaunch of outdoor marketing campaign
8th Mar 202211:03 amRNSShare purchase by CEO
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:00 amRNSExercise of Warrants
1st Mar 20227:00 amRNSLaunch of Rejuvenating Cannabinoid Face Serum
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20222:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:01 pmRNSPrice Monitoring Extension
21st Feb 202211:05 amRNSSecond Price Monitoring Extn
21st Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20229:05 amRNSSecond Price Monitoring Extn
21st Feb 20229:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSStrategy and trading update
2nd Feb 20227:00 amRNSWhite paper on cannabinoids and skin aging
7th Jan 20221:00 pmRNSResults of Annual General Meeting
15th Dec 20217:00 amRNSAnnual General Meeting update
8th Dec 20217:00 amRNSGrant of Options to CEO
6th Dec 20211:57 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSAppointment of new CEO
3rd Dec 20217:00 amRNSAnnual results
1st Dec 20217:00 amRNSLaunch of inaugural products & ecommerce platform
11th Nov 20217:00 amRNSAdvertising and PR agencies appointed
8th Nov 20212:05 pmRNSSecond Price Monitoring Extn
8th Nov 20212:00 pmRNSPrice Monitoring Extension
8th Nov 202111:05 amRNSSecond Price Monitoring Extn
8th Nov 202111:00 amRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSGrant of Share Options and update on warrants
4th Oct 20219:06 amRNSSecond Price Monitoring Extn
4th Oct 20219:00 amRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSDirector dealings & TR1 notification
16th Aug 20217:00 amRNSSupply agreement signed with Chanelle McCoy Health
2nd Aug 20217:00 amRNSShare disposal by significant shareholder
28th Jul 20212:06 pmRNSSecond Price Monitoring Extn
28th Jul 20212:00 pmRNSPrice Monitoring Extension
10th Jun 20217:00 amRNSSupply agreement signed with Willow Biosciences
25th May 20217:00 amRNSCellular Goods Interim Results
6th May 20217:00 amRNSGrant of Warrants and Extension of Exercise Period
20th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSCellular Goods boosts team with five appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.